Christian O. Henry holds the role of Director at Ginkgo Bioworks Holdings, Inc. (DNA). Henry's filing history also covers PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and Wave Life Sciences Ltd. (WVE). Henry has reported 9 insider filings with the SEC since 2025. The most recent filing was in June 2026.
Every role Christian O. Henry has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Updated Aug 31, 2026
Christian O. Henry is Director of Ginkgo Bioworks Holdings, Inc. (DNA). 8 SEC Form 4 filings on record going back to 2025, most recently on 15 June 2026. Most recent open-market trade: sold $19K of PACB on 4 March 2026. Lifetime open-market sales: $2.45M.
Every recent SEC Form 4 transaction Christian O. Henry has reported, most recent first.
InsiderAlpha's records for Christian O. Henry go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. 10 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Christian O. Henry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Christian O. Henry is a corporate insider, tracked as Director of Ginkgo Bioworks Holdings, Inc. (DNA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
1 primary Form 4 filing in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases and 10 open-market sales ($2.45M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
140.9K shares @ $1.63$229K